James Liao to Treatment Outcome
This is a "connection" page, showing publications James Liao has written about Treatment Outcome.
Connection Strength
0.402
-
Emerging views of statin pleiotropy and cholesterol lowering. Cardiovasc Res. 2022 01 29; 118(2):413-423.
Score: 0.079
-
The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia. Curr Vasc Pharmacol. 2019; 17(3):222-232.
Score: 0.064
-
Evidence of pleiotropy by statins: leukocyte Rho kinase (ROCK) activity and pretreated statin before percutaneous coronary interventions are clinical vascular outcome predictors. Int J Cardiol. 2014 Sep; 176(1):250-3.
Score: 0.047
-
Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina. Atherosclerosis. 2012 Apr; 221(2):521-6.
Score: 0.039
-
Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol. 2008 Mar; 28(3):s39-42.
Score: 0.030
-
Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer? Circulation. 2007 Mar 27; 115(12):1615-21.
Score: 0.028
-
Safety and efficacy of statins in Asians. Am J Cardiol. 2007 Feb 01; 99(3):410-4.
Score: 0.028
-
Drug Insight: statins and stroke. Nat Clin Pract Cardiovasc Med. 2005 Nov; 2(11):576-84.
Score: 0.026
-
Lipid management with statins. The lower the better? Z Kardiol. 2004 Jan; 93(1):4-9.
Score: 0.023
-
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Neurosurgery. 2019 12 01; 85(6):843-853.
Score: 0.017
-
A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome. Int J Cardiol. 2013 Sep 10; 167(6):2813-9.
Score: 0.010
-
Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg. 2004 Jun; 39(6):1178-85.
Score: 0.006
-
Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke. 2001 Apr; 32(4):980-6.
Score: 0.005